BLACK WEEKSFlakonai −15% · rinkiniai −10% · kita −5%su koduNemokamas siuntimas Vokietijoje nuo €200

Šis puslapis išverstas automatiškai ir jame gali būti klaidų. Ar lietuvių kalba yra jūsų gimtoji? Mielai sulauksime jūsų atsiliepimų ir pataisymų.Siųsti atsiliepimą

The Peptide Desk The Peptide Desk
Cagrilintide, produkto nuotrauka

Laboratorijos ataskaitų: 2

PDF
99%
Grynumas
Ištirta
Cagrilintide 10mg
Laboratorija
Analiza Białek
Data
November 2026
Rezultatas
99% purity (10.89 mg measured)
Endotoksinai
6.05 EU/vial
Užsakymo nr.
Slaptažodis

Ištirta nepriklausomai, su slaptažodžiu galima patikrinti tiesiogiai laboratorijoje.

Amylin

Cagrilintide

Amylin

Užsakymas

Vieneto kaina - Nemokamas siuntimas Vokietijoje nuo 200 € Black Weeks metu
  • DHL su sekimu
  • Diskreti pakuotė

4.6 iš 5 TrustpilotAtsiliepimų: 73

Taip pat ieškoma kaip: Cagrilintid · AM833

Trumpai

Cagrilintide skaičiais

Pagrindiniai rodikliai iš mūsų žinyno.

Visas žinyno įrašas
Class
Long-acting amylin analogue
Frequency
Once weekly
Form
Lyophilised powderreconstituted with BAC water
Sizes
5 to 20 mg3 sizes in the shop

Žinios

Viskas apie Cagrilintide

Išsami informacija netrukus.

Pravers

Ko dar jums reikės

Bakteriostatinis vanduo į krepšelį pridedamas automatiškai. Švirkštai ir servetėlės - vienu paspaudimu.

Insulino švirkštai

10 vnt. · 5.50 €

Spiritinės servetėlės

50 vnt. · 10 €

Kiek vandens?

Vienetai ant švirkšto jūsų flakono dydžiui.

Atidaryti skaičiuoklę →

FAQ

Dažnai užduodami klausimai

Šaltiniai kiekvienam atsakymui: žinyno įrašas

Dar turite klausimų?

Parašykite mums, mūsų komanda jums padės.

Is cagrilintide approved?

No, according to ChEMBL there is no approval (as of 25 October 2026). ClinicalTrials.gov lists 21 phase 3 trials, ten of them completed. Most test the combination with semaglutide. Cagrilintide alone is being tested in phase 3 in the RENEW trials, with the primary endpoint planned for May 2027.

How does cagrilintide differ from GLP-1 compounds such as semaglutide?

The receptor. Cagrilintide binds to amylin and calcitonin receptors, not to the GLP-1 receptor. In rats it acted through specific nerve cells in the brainstem: when a signal there was switched off, the effect of cagrilintide disappeared but that of semaglutide did not. That is why the combination of the two is being studied.

What did the phase 2 trial show?

In the dose-finding trial with 706 participants weight fell by 6.0 to 10.8 percent after 26 weeks depending on the level, by 3.0 percent on placebo. At the highest level, 53 percent lost at least 10 percent according to the registry, on placebo 10 percent.

How long does cagrilintide stay in the body?

The half-life was 159 to 195 hours in a phase 1b study, so about seven days. That fits one dose a week, which is how the trials give it. With impaired kidney or liver function the level after a single dose was not meaningfully different.

What does the combination with semaglutide add?

In REDEFINE 1 weight fell by 20.4 percent on average after 68 weeks, by 3.0 percent on placebo. With type 2 diabetes (REDEFINE 2) it was 13.7 versus 3.4 percent. In a phase 2 trial in type 2 diabetes participants lost 15.6 percent in 32 weeks with the combination, 8.1 with cagrilintide alone and 5.1 percent with semaglutide alone.

Which side effects were seen?

Most often gastrointestinal effects, above all nausea: in the phase 2 trial 20 to 47 percent had it depending on the level, 18 percent on placebo. Constipation, injection site reactions and, at the highest level, more frequent fatigue came on top. The QT interval on the ECG did not lengthen relevantly in a dedicated study.

Which trials are still running?

Eleven phase 3 trials are not finished yet. The largest is REDEFINE 3 on cardiovascular events with 7,101 participants (primary endpoint planned for September 2027). For cagrilintide alone RENEW 1, 2 and 4 are running, plus a trial in children and adolescents until 2030.

Susiję

Susiję produktai